Pure Global

Hiv-1 Genotyping Assay Using Ngs Technology

Hiv-1 Genotyping Assay Using Ngs Technology is a medical device type in the Medical Genetics specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.

Global Registration Data
Multi-Country Intelligence
Hiv-1 Genotyping Assay Using Ngs Technology
Medical Genetics Medical Device Type
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Regulatory Classifications

US Regulatory Classifications

QIC

View Product Code Classification

Class 2

21 CFR 866.3955

View CFR Regulation

Medical Genetics

Device Characteristics

No

No

No

Not Eligible

Definition

The human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing (NGS) technology is a prescription in vitro diagnostic device intended for use in detecting HIV genomic mutations that confer resistance to specific anti-retroviral drugs. The device is intended to be used as an aid in monitoring and treating HIV infection.

Search Keywords

Click to search for similar devices in our global database